Concepedia

Donald G. Osinga

DG

Statistics

Publications

3

Citations

102

H-Index

3

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Donald G. Osinga is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and acute lung injury.

Publications per year

1989–1991

3

Publications

3

A Comparison of α1-Proteinase Inhibitor Methoxysuccinyl-Ala-Ala-Pro-Val-Chloromethylketone and Specific β-Lactam Inhibitors in an Acute Model of Human Polymorphonuclear Leukocyte Elastase-induced Lung Hemorrhage in the Hamster

Daniel S. Fletcher, Donald G. Osinga, Karen M. Hand et al. · American Review of Respiratory Disease · 1990 · 44 citations

, , +13

Pharmacological profile of the substituted beta‐lactam L‐659,286: A member of a new class of human PMN elastase inhibitors

Robert J. Bonney, Bonnie M. Ashe, Alan L. Maycock et al. · Journal of Cellular Biochemistry · 1989 · 30 citations

, , +11

Prevention of human leukocyte elastase-mediated lung damage by 3-alkyl-4-azetidinones

William K. Hagmann, Shrenik K. Shah, Conrad P. Dorn et al. · Bioorganic & Medicinal Chemistry Letters · 1991 · 28 citations

, , +6

1–3 of 3